Anti-Infectives

Ciprofloxacin can prevent infection in pediatric cancer patients

Published in TB and Outbreaks Week, April 27th, 2004

Ciprofloxacin can prevent infection in children who undergo stem-cell transplantation for cancer, although its use is not universally recommended.

Researchers in New York evaluated results from "clinical trials of outpatient management of fever and neutropenia in pediatric cancer patients.

"A number of clinical trials in a wide range of clinical settings and countries have demonstrated that low-risk pediatric cancer patients with fever and neutropenia can be prospectively identified and safely treated as outpatients," reported C.A. Mullen and coauthors at the University of Rochester.

"In addition, outpatient management has been...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2004-04-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry